BackAvadel Pharmaceuticals plc Overview

Avadel Pharmaceuticals plc Cost of Revenue

Cost of Revenue analysis for AVDL.

Quarterly Cost of Revenue

$-3001000.00
↓ 148.76% YoY

As of Sep 30, 2025

Annual Cost of Revenue (TTM)

$13.75M
↑ 23.27% YoY

Trailing 12 months ending Sep 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin